Brind.

Telix Pharmaceuticals acquired RLS and received FDA approval for a label expansion of its drug Illuccix.

2 reports, 0 independent Updated Jun 30

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Telix Pharmaceuticals acquired RLS and received FDA approval for a label expansion of its drug Illuccix.

Who's involved

What this event is mainly about

TELIX PHARMACEUTICALS LIMITED FDA

Keep exploring

The entities involved

TELIX PHARMACEUTICALS LIMITED
Australian public company

Nothing else this week.
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Related events

Coverage

Newest first; wire copies grouped

Jun 30Unknown outlet
Jun 23Unknown outlet